Svenska
Home
About
Active Biotech in Brief
Board of Directors
Management
Business Concept
Corporate Governance
Corporate Governance Report 2019
Article of Association
Audit committee
Scientific committee
Election Committee
General Meetings
Auditors
Partnerships
Career
Projects
Project Overview
Naptumomab
Tasquinimod
Laquinimod
Patents
Orphan Drug Designation
Investor
Investor
Analyst coverage
Financial Calendar
Financial Reports
Interim Reports
Annual Reports
Stock
Ownership
Official Documents
Rights Issue 2014
Rights Issue 2016
Rights Issue 2018
Rights Issue 2021
Media
Press Contact
Press Releases
Subscribe
News
Company Presentation
Image Bank
Contact
Copyright © 2021 Active Biotech AB.
All Rights Reserved.
Design by
Clavis Communications
.
Investor
Investor
Analyst coverage
Financial Calendar
Financial Reports
Interim Reports
Annual Reports
Stock
Ownership
Official Documents
Interim Reports
2020
Active Biotech Interim report January – September 2020
November 5, 2020 07:45 (CET)
Active Biotech Interim Report Jan-Jun 2020
August 6, 2020 08:30 (CEST)
Active Biotech Interim Report January - March 2020
April 23, 2020 08:30 (CEST)
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
This site uses cookies.
Okay, thanks